American Council of Cannabis Medicine Forms Advisory Council
The American Council of Cannabis Medicine (ACCM) has formed the ACCM Industry Leadership Advisory Council to provide the necessary resources and guidance to advance a comprehensive medical cannabis package that allows professionalization, clinical research and greater access.
“The Council is made up of some of the finest people and organizations in the industry. They truly want to make a difference and help people,” said Glen Caroline, head of advocacy at WAB Strategic and ACCM Outreach Committee co-chair. “Their experience and knowledge provide a critical asset for our work with legislators. They are engaged first and foremost with our legislative teams Senate efforts, but also working with our targeted state work and Yes We Cann! national advocacy program.”
Several members of the Council have been working with the ACCM Alliance on multiple legislative and advocacy issues. The Council represents ACCM’s further commitment to support legislation that allows research and access.
The American Council of Cannabis Medicine is the “Voice of American Medical Cannabis.” ACCM represents America’s medical-cannabis industry, which supports millions of U.S. jobs and is backed by a growing grassroots movement supporting millions of beneficiaries. Members produce, process, and distribute medical cannabis through state-licensed programs, supporting companies, healthcare industry, physicians, researchers, health/wellness providers, insurance companies, systems, and patient advocacy groups. They participate in ACCM’s 14 standing area-centric committees. ACCM was started in 2016 as a Capitol Hill working group and has developed into a mission-driven 501c4. Its pressing objective is to facilitate legislation that advances medical cannabis at the federal level and improve state access.
Reach the American Council of Cannabis Medicine at 202-349-9650, or visit www.accmforum.org.
